Shailendra Dwivedi to Antineoplastic Agents
This is a "connection" page, showing publications Shailendra Dwivedi has written about Antineoplastic Agents.
Connection Strength
0.485
-
Inhibition of BMI1, a Therapeutic Approach in Endometrial Cancer. Mol Cancer Ther. 2018 10; 17(10):2136-2143.
Score: 0.103
-
MDR1 mediated chemoresistance: BMI1 and TIP60 in action. Biochim Biophys Acta. 2016 08; 1859(8):983-93.
Score: 0.089
-
Amino acids derived benzoxazepines: design, synthesis and antitumor activity. Bioorg Med Chem Lett. 2013 Dec 15; 23(24):6816-21.
Score: 0.074
-
Specific targeting of insulin-like growth factor 1 receptor signaling in human estrogen dependent breast cancer cell by a novel tyrosine-based benzoxazepine derivative. Mol Cell Endocrinol. 2011 May 16; 338(1-2):68-78.
Score: 0.062
-
Anti-tumor activity of a new series of benzoxazepine derivatives in breast cancer. Bioorg Med Chem Lett. 2010 Jan 01; 20(1):283-7.
Score: 0.056
-
Synthesis and biological evaluation of 3,4,6-triaryl-2-pyranones as a potential new class of anti-breast cancer agents. Bioorg Med Chem. 2009 Jun 01; 17(11):3847-56.
Score: 0.054
-
Evaluating the Mechanism and Therapeutic Potential of PTC-028, a Novel Inhibitor of BMI-1 Function in Ovarian Cancer. Mol Cancer Ther. 2018 01; 17(1):39-49.
Score: 0.024
-
MICU1 drives glycolysis and chemoresistance in ovarian cancer. Nat Commun. 2017 05 22; 8:14634.
Score: 0.024